572 related articles for article (PubMed ID: 34288803)
1. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
2. An immune-related lncRNA signature for patients with anaplastic gliomas.
Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
4. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
Xia P; Li Q; Wu G; Huang Y
Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis.
Zhang S; Wang W; Liu G; Xie S; Li Q; Li Y; Lin Z
Biomed Pharmacother; 2017 Nov; 95():711-720. PubMed ID: 28886531
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
7. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
Liang Q; Guan G; Li X; Wei C; Wu J; Cheng P; Wu A; Cheng W
J Transl Med; 2020 Oct; 18(1):378. PubMed ID: 33028341
[TBL] [Abstract][Full Text] [Related]
8. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.
Kiran M; Chatrath A; Tang X; Keenan DM; Dutta A
Mol Neurobiol; 2019 Jul; 56(7):4786-4798. PubMed ID: 30392137
[TBL] [Abstract][Full Text] [Related]
9. Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation.
Gao Y; Liu J; Cai B; Chen Q; Wang G; Lu Z; Jiang K; Miao Y
Bioengineered; 2021 Dec; 12(2):10553-10567. PubMed ID: 34854360
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
[TBL] [Abstract][Full Text] [Related]
11. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/β-catenin signaling pathways.
He L; Yang H; Zhu XL; Zhang Y; Lv K
Brain Res Bull; 2021 Nov; 176():112-120. PubMed ID: 34474120
[TBL] [Abstract][Full Text] [Related]
13. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation.
Xin S; Huang K; Zhu XG
Pathol Res Pract; 2019 Sep; 215(9):152539. PubMed ID: 31387808
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Glioma Cells.
Zeng J; Du T; Song Y; Gao Y; Li F; Wu R; Chen Y; Li W; Zhou H; Yang Y; Pei Z
Oncol Res; 2017 Jul; 25(6):913-921. PubMed ID: 27938499
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
17. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
18. Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas.
Li S; Chen Y; Guo Y; Xu J; Wang X; Ning W; Ma L; Qu Y; Zhang M; Zhang H
PeerJ; 2023; 11():e15810. PubMed ID: 37547724
[TBL] [Abstract][Full Text] [Related]
19. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
[TBL] [Abstract][Full Text] [Related]
20. LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas.
Wang W; Yang F; Zhang L; Chen J; Zhao Z; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
Oncotarget; 2016 Nov; 7(47):77225-77236. PubMed ID: 27764782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
